These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29089624)

  • 1. Combating virulence of Gram-negative bacilli by OmpA inhibition.
    Vila-Farrés X; Parra-Millán R; Sánchez-Encinales V; Varese M; Ayerbe-Algaba R; Bayó N; Guardiola S; Pachón-Ibáñez ME; Kotev M; García J; Teixidó M; Vila J; Pachón J; Giralt E; Smani Y
    Sci Rep; 2017 Oct; 7(1):14683. PubMed ID: 29089624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic activity of an OmpA inhibitor and colistin against colistin-resistant Acinetobacter baumannii: mechanistic analysis and in vivo efficacy.
    Parra-Millán R; Vila-Farrés X; Ayerbe-Algaba R; Varese M; Sánchez-Encinales V; Bayó N; Pachón-Ibáñez ME; Teixidó M; Vila J; Pachón J; Giralt E; Smani Y
    J Antimicrob Chemother; 2018 Dec; 73(12):3405-3412. PubMed ID: 30188994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outer membrane protein A (OmpA) as a potential therapeutic target for Acinetobacter baumannii infection.
    Nie D; Hu Y; Chen Z; Li M; Hou Z; Luo X; Mao X; Xue X
    J Biomed Sci; 2020 Jan; 27(1):26. PubMed ID: 31954394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Hypoxia on the Pathogenesis of Acinetobacter baumannii and Pseudomonas aeruginosa In Vitro and in Murine Experimental Models of Infection.
    Gil-Marqués ML; Pachón-Ibáñez ME; Pachón J; Smani Y
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antivirulence activity of several d-amino acids against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Rumbo C; Vallejo JA; Cabral MP; Martínez-Guitián M; Pérez A; Beceiro A; Bou G
    J Antimicrob Chemother; 2016 Dec; 71(12):3473-3481. PubMed ID: 27605598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Virulence Capabilities and ompA Expressions in ST2 and ST513 of Multidrug-Resistant Acinetobacter baumannii.
    Shirazi AS; Shafiei M; Solgi H; Aslani MM; Azizi O; Badmasti F
    Curr Microbiol; 2019 Jun; 76(6):723-731. PubMed ID: 30989324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel bacterial transport mechanism of Acinetobacter baumannii via activated human neutrophils through interleukin-8.
    Kamoshida G; Tansho-Nagakawa S; Kikuchi-Ueda T; Nakano R; Hikosaka K; Nishida S; Ubagai T; Higashi S; Ono Y
    J Leukoc Biol; 2016 Dec; 100(6):1405-1412. PubMed ID: 27365529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IOX1 activity as sepsis therapy and an antibiotic against multidrug-resistant bacteria.
    Lee SJ; You JS; Gharbi A; Kim YJ; Lee MS; Kim DH; Lee KW; Jung ID; Park YM
    Sci Rep; 2021 Feb; 11(1):2942. PubMed ID: 33536477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J; Dofferhoff AS; Mouton JW; van der Meer JW
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
    Vasudevan A; Mukhopadhyay A; Li J; Yuen EG; Tambyah PA
    BMC Infect Dis; 2014 Nov; 14():615. PubMed ID: 25420613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methoxy-Substituted Hydroxychalcone Reduces Biofilm Production, Adhesion and Surface Motility of Acinetobacter baumannii by Inhibiting ompA Gene Expression.
    Ušjak D; Dinić M; Novović K; Ivković B; Filipović N; Stevanović M; Milenković MT
    Chem Biodivers; 2021 Jan; 18(1):e2000786. PubMed ID: 33188577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
    Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
    PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models.
    McConnell MJ; Actis L; Pachón J
    FEMS Microbiol Rev; 2013 Mar; 37(2):130-55. PubMed ID: 22568581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
    Navon-Venezia S; Ben-Ami R; Carmeli Y
    Curr Opin Infect Dis; 2005 Aug; 18(4):306-13. PubMed ID: 15985826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colicin-like bacteriocins as novel therapeutic agents for the treatment of chronic biofilm-mediated infection.
    Brown CL; Smith K; McCaughey L; Walker D
    Biochem Soc Trans; 2012 Dec; 40(6):1549-52. PubMed ID: 23176515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Mutation of Conservative Asp268 Residue in the Peptidoglycan-Associated Domain of the OmpA Protein Affects Multiple
    Skerniškytė J; Karazijaitė E; Deschamps J; Krasauskas R; Briandet R; Sužiedėlienė E
    Molecules; 2019 May; 24(10):. PubMed ID: 31121924
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Cefiderocol against Carbapenem-Resistant Gram-Negative Bacilli in Immunocompetent-Rat Respiratory Tract Infection Models Recreating Human Plasma Pharmacokinetics.
    Matsumoto S; Singley CM; Hoover J; Nakamura R; Echols R; Rittenhouse S; Tsuji M; Yamano Y
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of serum resistance for Pseudomonas aeruginosa and Acinetobacter baumannii strains].
    Cevahir N; Kaleli I; Demir M; Yildirim U; Cevik E; Gürbüz M
    Mikrobiyol Bul; 2006 Jul; 40(3):251-5. PubMed ID: 17001855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.